Automatic cell culture station. Period of performance warranty: september 16, 2022 - september 15, 2023.
Ended Purchase Order Awarded
- Contract number
- 75N95022P00642
- Awardee
-
Cellink LLC UEI QCK1LDJ3A6K5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $151,928
Award facts
- Opportunity
-
- Automatic cell culture station including liquid handler, L. Drop, thermoplate and incubator and live cell imager, the Cellcyte X Pre-Solicitation · 75N95022Q00418 · Posted Jul 13, 2022
- Contract value 100% obligated
- $151,928.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Blacksburg, VA, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the acquisition of an automatic cell culture station, including a liquid handler, thermoplate, incubator, and live cell imager, by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract was awarded to Cellink LLC, a foreign-owned, for-profit organization, on a firm-fixed price basis for a potential value of $151,928.00. The contract has a period of performance from September 16, 2022, to September 15, 2023, with a 12-month basic warranty and first year of software subscription provided. This acquisition supports the mission of the NINDS Translational Neuroscience Center to develop in vitro 3D organoid models for studying neural development, degeneration, and pathology, including infectious diseases affecting the human brain. The contract did not utilize a small business set-aside.
Quick answers
Who was awarded contract 75N95022P00642?
75N95022P00642 was awarded to Cellink LLC by National Institute on Drug Abuse (National Institutes of Health) on September 16, 2022.
How much is contract 75N95022P00642 worth?
The government has obligated $151,928 on 75N95022P00642.
Which agency awarded contract 75N95022P00642?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00642, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95022P00642 competed?
The extent of competition for 75N95022P00642 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award